Treatment Information

Back

Bladder Cancer treatment details. Chemotherapy.

Istituto Neurotraumatologico Italiano, Rome, Italy.

Survival: monthsCountry:Italy
Toxiciy Grade:4City/State/Province:Rome
Treatments:ChemotherapyHospital:Istituto Neurotraumatologico Italiano
Drugs:Journal:Link
Date:Dec 2011

Description:

Patients:
This phase 2 trial involved 44 previously treated metastatic urothelial carcinoma patients with a median age of 64 years; 83% were male.

Treatment:
Patients were treated with the chemotherapy agents epirubicin and paclitaxel.

Toxicities:
The most severe adverse event was grade 4 neutropenia. Grade 3 fatigue and grade 2 alopecia were reported.

Results:
The median overall survival time was 12.6 months.

Correspondence: Dr. Antonio Rozzi; email: [email protected]



Back